Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Topotecan-Monotherapy Vs. Topotecan + Etoposide Vs. Topotecan + Gemcitabine in Therapy in Patients With Recurrent Ovarian Cancer

NCT00312988 is registered in ClinicalTrials.gov with North Eastern German Society of Gynaecological Oncology as lead sponsor.

NCT NCT00312988
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00312988 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Topotecan-Monotherapy Vs. Topotecan + Etoposide Vs. Topotecan + Gemcitabine in Therapy in Patients With Recurrent Ovarian Cancer
Lead sponsor
North Eastern German Society of Gynaecological Oncology
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2000
Completion date
December 31, 2009
Enrollment
450
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer